Clinical Trial Update: This Study Tests How Healthy Men Tolerate Different Doses of BI 730357 and How the Metabolism of Midazolam is Affected by BI 730357 [Phase 1]

View source ↗

Summary

A Phase 1 trial evaluating tolerability of varying doses of BI 730357 in healthy men and how BI 730357 affects the metabolism of midazolam, with psoriasis inclu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Psoriasis

Drugs mentioned

• BI 730357
• Midazolam (Midazolam)

Snippet

Sponsor: Boehringer Ingelheim | Conditions: Healthy, Psoriasis | Phase 1 | Status: COMPLETED | Results posted: 2023-09-21